Hayder Saeed: Chemo-Free Frontline Therapy Shows Promise in Frail Patients With DLBCL
Hayder Saeed/ X

Hayder Saeed: Chemo-Free Frontline Therapy Shows Promise in Frail Patients With DLBCL

Hayder Saeed, Associate Vice President at Tampa General Hospital, shared on X:

“Chemo-free frontline therapy for frail DLBCL is starting to look real.

R-Pola-glo, median age 80, 92% unfit/frail: CMR 80% at EOT, 2-yr PFS 80% (n=126).

Single-arm, 4 fatal infections, phase 3 next. Could it replace R-mini-CHOP for the frailest?”

Title: 621 Phase II frontline chemofree R-Pola-glo trial induces high and durable response rates in elderly and medically unfit/frail patients with aggressive B-cell lymphoma: Combined analysis of the initial and extension cohorts and extended follow-up

Authors: Björn Chapuy, Rebecca Wurm-Kuczera, Ralph Michael, Meng Wang, Shashwat Sahay, Salaheddine Ali, Bettina Altmann, Petra Pichler-Izmir, Angela Huster, Andrea Kerkhoff, Michael Panny, Roland Schroers, Anna Ossami Saidy, Fabian Müller, Frederik Damm, Manuel Orlinger, Philipp B Staber, Carsten Schwaenen, Luisa Wohn, Ruppert Langer, Mario Mairhofer, Martin Hoffmann, Mathias Hänel, Johannes Duell, Simone Heyn, Stephanie Mayer, Thomas Weber, Peter Reimer, Natalia Magdalena Rotter, Ulf Schnetzke, Bastian von Tresckow, Gabriel Kammerer, Julia Rasvina, Barbara Lehner, Thomas Mika, David Böckle, Corinna Leng, Anna Lena Illert, Birte Friedrichs, Ella Willenbacher, Dimitrios Mougiakakos, Christiane Pott, Salah Al-Batran, Clemens A. Schmitt, Andreas Rosenwald, Dirk Hellwig, Sascha Dietrich, Bertram Glass, Georg Lenz, Ulrich Keller, Marita Ziepert, Thomas Melchardt, Richard Greil

Read the full paper.

You can also read: